Outpatient management of intussusception: a systematic review and meta-analysis
jpedsurg.org shows its articles on its own site.
Read the article on jpedsurg.org ↗Article · Nov 2018 · 1 min read
In brief
In brief
Systematic review comparing inpatient versus outpatient management after successful enema reduction for intussusception in children. Findings demonstrate no significant difference in recurrence rates, ED returns, or need for surgery, suggesting outpatient management may be safe and reduce hospital resource utilization.
Written by the GCMD Library team from the article.
Background
Variability in management of intussusception after enema reduction exists. Historically, inpatient observation was recommended; however, there is a lack of evidence-based guidelines for this practice.
Methods
A systematic review and meta-analysis evaluating outcomes between inpatient (IP) and outpatient (OP) management after enema reduction was performed. The following databases were searched: PubMed, EBSCOhost CINAHL, EMBASE, Web of Science, and Cochrane Database. Data from an institutional review were included in the meta-analysis.
Results
Ten studies of patients aged 0–18 years with intussusception who underwent successful enema reduction that reported outcomes of outpatient management were included. Overall recurrence rates were 6% for IP and 8% for OP (p = 0.20). Recurrences within 24 (IP: 1% vs OP: 0%, p = 0.90) and 48 h (IP: 1% vs OP: 2%, p = 0.11) were similar. There was no significant difference in the rate of return to the emergency department (IP: 6% vs OP: 14%, p = 0.11). Both groups had a similar rate of requiring an operation (IP: 2% vs OP: 1%, p = 0.84).
Conclusions
Outpatient management of intussusception after enema reduction results in a shorter hospital stay with no difference in the rate of return to the emergency department, recurrence, need for operation, or mortality. The findings of the meta-analysis suggest that outpatient management may be safe and could reduce hospital resource utilization.
Type of study
Treatment study.
Level of evidence
III.
